Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d302e9bb-da3f-4c83-9fc4-b8fedf0c3342&Preview=1 Date 12/28/2011 Company Name MobileDay Mailing Address 1919 14th Street Boulder, CO 80302 Company Description MobileDay provides One-Touch access into any conference call. Painlessly connect into any call with your Android or iPhone. Website http://www.mobileday.com Transaction Type Venture Equity Transaction Amount $1,475,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “MobileDay Obtains $1,475,000 New Financing Round”
Bacteria to Do Our Bidding
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Broad claims covering delivery of therapeutics using engineered bacteria. Synthetic biology tools emerging in just the last few years have made this possible. The trick, of course, is precise control. If I … Continue reading “Bacteria to Do Our Bidding”
12 Big Questions for Seattle Tech in 2012
I don’t want to read too much into the arbitrary turn of the calendar, but it seems like we’re in the middle of a pretty interesting moment for Seattle’s technology scene. One of our mega-companies may be on the wane, while the other appears to be headed for much bigger things. The startup scene is … Continue reading “12 Big Questions for Seattle Tech in 2012”
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011
Ever since Xconomy added New York to its stable of cities on April 1, we have found plenty of companies to write about that are making waves in tech, biotech, and cleantech. We’ve met tech entrepreneurs who’ve caught the fancy of New York’s thriving venture capital scene, and scientists in the bowels of Big Pharma … Continue reading “Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011”
Beyond the iPad to the hPad
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Two patents: a. A low-cost holographic pad: an “hPad,” which would sit on your desk and project three-dimensional fixed and moving images. It would include a touchscreen-like functionality. This would not only … Continue reading “Beyond the iPad to the hPad”
OnChip Power Garners $1,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4967417d-1eb5-4e45-91cf-398d4839c4ee&Preview=1 Date 12/27/2011 Company Name OnChip Power Mailing Address One Cambridge Center 6th Floor Cambridge, MA 02142 Company Description The company develops power electronics technology. Website http://www.onchippower.com Transaction Type Venture Equity Transaction Amount $1,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing-amended. M&A Terms Venture Investor Undisclosed
Trada Receives $9,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d9fcafa-2e9a-4c05-b4aa-c52f8b77ee9c&Preview=1 Date 12/27/2011 Company Name Trada Mailing Address 1023 Walnut Street Boulder, CO 80302 Company Description Trada is revolutionizing the way Agencies, Advertisers and PPC Experts build and manage PPC marketing campaigns. We’ve developed the first PPC marketplace that allows agencies and in-house advertisers to leverage the skills of hundreds of the … Continue reading “Trada Receives $9,000,000 New Round”
Owncloud Secures $820,797 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a57e8a1e-6038-4b34-8af4-630a3f851e2e&Preview=1 Date 12/26/2011 Company Name Owncloud Mailing Address 12 Foster Road Lexington, MA 02421 Company Description ownCloud gives you universal access to your files through a web interface or WebDAV. It also provides a platform to easily view & sync your contacts, calendars and bookmarks across all your devices and enables basic … Continue reading “Owncloud Secures $820,797 New Financing Round”
Accellion Obtains $12,150,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7dee447-a47e-4714-bc16-a0a770b4774e&Preview=1 Date 12/26/2011 Company Name Accellion Mailing Address 1804 Embarcadero Road Palo Alto, CA 94303 Company Description Accellion, Inc provides enterprise-class secure file sharing solutions that provide the ease-of-use employees need, while giving the enterprise organization the security protection it needs. Website http://www.accellion.com Transaction Type Venture Equity Transaction Amount $12,150,000 Transaction Round … Continue reading “Accellion Obtains $12,150,000 New Financing”
Pall Corporation Acquires ForteBio for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ccf6fc3-57f4-4862-868a-1f0cf42718ee&Preview=1 Date 12/26/2011 Company Name ForteBio Mailing Address 1360 Willow Road Menlo Park, CA 94025 Company Description ForteBio is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification and characterization of protein interaction. Website http://www.fortebio.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds … Continue reading “Pall Corporation Acquires ForteBio for Undisclosed Sum”
A Detroit Mom’s Quest to Breathe Innovation Into Young Minds
I’m fond of saying that what Detroit needs is a Cory Booker. But I need to amend that: What Detroit really needs is a few more people like Ida Byrd-Hill, the founder of Uplift Inc., a startup whose motto is “Utilizing intellectual property, real estate, and technology to lift people out of tragedy by reconstructing cities … Continue reading “A Detroit Mom’s Quest to Breathe Innovation Into Young Minds”
Seattle Rewind: AT&T-Mo, Google, Amazon, Angels & More
AT&T shook up a potentially drowsy holiday week with the news that it was abandoning its $39 billion bid for Bellevue, WA-based T-Mobile. Ma Bell and T-Mo’s parent, Deutsche Telekom, telegraphed the end of their deal a week earlier when they got a federal antitrust lawsuit suspended. It seemed for a while like maybe there … Continue reading “Seattle Rewind: AT&T-Mo, Google, Amazon, Angels & More”
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles
Seattle-based Allozyne wasn’t able to go public this year, so it has fallen back on Plan B, tapping its existing venture capital backers one more time in a bid to create more value around its lead multiple sclerosis drug candidate. Allozyne, which has spent about $50 million since its founding in 2005 and was down … Continue reading “Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles”
TripAdvisor Post-IPO: Five Things We Learned From CEO Stephen Kaufer
Merry Christmas, Boston. You asked for it, and you got it. A big, publicly traded consumer tech company to put us on the map alongside the Silicon Valley bad boys and uppity New Yorkers. I present to you: TripAdvisor (NASDAQ: [[ticker:TRIP]]). Sure, we already have Zipcar (NASDAQ: [[ticker:ZIP]]), Carbonite (NASDAQ: [[ticker:CARB]]), iRobot (NASDAQ: [[ticker:IRBT]]), and … Continue reading “TripAdvisor Post-IPO: Five Things We Learned From CEO Stephen Kaufer”
Google Becomes Technology Partner with IncubateNYC Campaign in Harlem
Google has signed on as a technology partner with IncubateNYC’s campaign to establish a technology incubator in Harlem, says Marcus Mayo, co-founder of IncubateNYC. The group is competing to be chosen by the New York City Economic Development Corporation to fulfill a request for proposals for a new incubator to be established near 125th Street. … Continue reading “Google Becomes Technology Partner with IncubateNYC Campaign in Harlem”
WGBH Xconomy Report: TripAdvisor, Amazon, & More
Our partnership with the folks at WGBH continues as we join forces again this week to bring you the Xconomy Report. In this week’s innovation news, TripAdvisor goes public and independent, breaking ties with Expedia. Seattle-based Amazon.com makes plans for a Boston-area office, which will open in Cambridge early next year. And much more, including … Continue reading “WGBH Xconomy Report: TripAdvisor, Amazon, & More”
Beyond the Tablet Wars: Apple, Amazon, and the Cloud
Much has been written on the battle between Apple and Amazon. Certainly Steve Jobs’ passing has made us all reflect, and perhaps on a much deeper level than before, on the man and the empire he created. In many ways, the companies are more alike than they are different. What makes them both remarkable players … Continue reading “Beyond the Tablet Wars: Apple, Amazon, and the Cloud”
Momenta, Baxter Team Up on Biosimilars
Illinois-based Baxter International (NYSE: [[ticker:BAX]]) is tapping into Cambridge, MA-based Momenta Pharmaceuticals’ abilities as a generic drugmaker in a new collaboration deal focused on developing so-called biosimilars, or knockoffs of biologic drugs. Momenta (NASDAQ: [[ticker:MNTA]]) will receive $33 million upfront in the deal, according to an announcement yesterday, and could receive another $419 million in potential milestones … Continue reading “Momenta, Baxter Team Up on Biosimilars”
Business Plan Presentations: Innovations in Digital Commerce
Join MIT Enterprise Forum of NYC to hear from five early-stage companies, each of whom will have 5 minutes to pitch their e-commerce-related business, followed by engaging commentary and critique. The panel discussion will be moderated by Lori Hoberman, a partner at Chadbourne & Parke LLP. Register here.
Acceleron Adds $30M From Partner Celgene and Existing Investors
Cambridge, MA-based Acceleron Pharma announced today that it has raised $30 million in a private financing round. One of the participants in this round was Summit, NJ-based Celgene (NASDAQ: [[ticker:CELG]]), which has a partnership with Acceleron to develop two drugs to treat anemia. The two companies expanded their partnership most recently in August, when Celgene … Continue reading “Acceleron Adds $30M From Partner Celgene and Existing Investors”
Boston’s Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers
According to the National Science Foundation, eighth grade girls are half as likely to be interested in science, technology, engineering and math (STEM) careers as boys—a dramatic change from second grade, where the numbers are roughly equal. This trend continues through high school, college and into the workplace, as even women with advanced science degrees … Continue reading “Boston’s Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers”
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine
The sale of Amira Pharmaceuticals will likely go down as one of the standout life sciences deals of 2011—it certainly ranks as one of the biggest payouts in San Diego, where Amira was founded in 2005. But what may be more significant than hitting the bell in the strongman game at the biotech carnival is … Continue reading “A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine”
The Year in Seattle Medical Devices, Diagnostics, Health IT
Yesterday, we ran the first half of the Seattle life sciences year in review, which focused on biopharmaceutical companies and global health organizations. Today’s rundown will cover the medical device, diagnostic, and health IT side of the local life sciences cluster. Medical devices may not fare so well in a glamour contest, but this year … Continue reading “The Year in Seattle Medical Devices, Diagnostics, Health IT”
Avalon’s Kinsella Toasts Debut Vintage of Another Venture
Avalon Ventures founder Kevin Kinsella has demonstrated his prowess in biotech deals, and even in backing an occasional Broadway musical. Now, just in time for the holidays, he’s uncorking the debut vintage of cabernet sauvignon from Kinsella Estates, a winery he and his wife Tamara acquired in Northern California’s Sonoma County four years ago. “The … Continue reading “Avalon’s Kinsella Toasts Debut Vintage of Another Venture”
15 Great Apps for that iPad Under the Tree
The iPad 2 won’t be the only tablet turning up as a holiday gift this year: it’s finally got some real competition in the form of the more affordable Kindle Fire. But let’s face it: you don’t buy (or give someone) a Kindle Fire because of the apps. The device is designed primarily as a … Continue reading “15 Great Apps for that iPad Under the Tree”
Enabling the Cleantech Revolution
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] It is a very dynamic time for the emerging cleantech market, and success will only be ensured if strong technologies are combined in systems that work the first time. So, if I … Continue reading “Enabling the Cleantech Revolution”
24-Hour, Full-Genome Scans
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] A DNA sequencing technology that results in full genome scans in less than 24 hours. This would enable real-time profiling of cancer patients, which would be of tremendous value in determining the … Continue reading “24-Hour, Full-Genome Scans”
Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines
Big drug collaborations and acquisitions took the spotlight in the New England life sciences news pool this week. —Coronado Biosciences, which moved from New York to Burlington, MA, this past August, debuted on the Nasdaq stock exchange, with an opening share price of $6.50 on Monday. The company (NASDAQ: [[ticker:CNDO]]) went public not through a conventional … Continue reading “Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines”
Acceleron Pharma Lands $30,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a9156b52-c8b4-4945-958e-014b02e68551&Preview=1 Date 12/23/2011 Company Name Acceleron Pharma Mailing Address 128 Sidney Street Cambridge, MA 02139 Company Description Acceleron is establishing itself as the premier company in GDF-targeted therapies. We have developed an unparalleled expertise in GDF biology, and our scientific advisory board consists of leaders and pioneers in the field. Website http://www.acceleronpharma.com … Continue reading “Acceleron Pharma Lands $30,000,000 New Financing”
Proacta Secures $500,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=57c36bcd-f159-4e7f-b37c-ddebdb49f45d&Preview=1 Date 12/23/2011 Company Name Proacta Mailing Address 4275 Executive Square La Jolla, CA 92037 Company Description Proacta is developing a new generation of cancer drugs that uniquely target physiological attributes of solid tumors. Proacta’s first lead program, a hypoxia targeted small-molecule prodrug, is designed to improve the outcomes of current treatment … Continue reading “Proacta Secures $500,000 New Financing”
Addmired Lands $5,269,986 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22bdcffe-9001-4f75-b339-1f7861e03925&Preview=1 Date 12/23/2011 Company Name Addmired Mailing Address 555 Hamilton Avenue Palo Alto, CA 94301 Company Description Addmired, Inc. is a software company in Sunnyvale, CA, focused on creating new and engaging applications and games for users of social networks and mobile devices. Website http://www.addmired.com Transaction Type Venture Equity Transaction Amount $5,269,986 … Continue reading “Addmired Lands $5,269,986 Series A Funding Round”
Quantcast Secures $7,999,999 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c43fa8a2-cb65-4d67-a3b7-d155bd8a8eba&Preview=1 Date 12/23/2011 Company Name Quantcast Mailing Address 201 Third St. Second Floor San Francisco, CA 94103 Company Description Quantcast is the world’s first open Internet ratings service. The free service provides deep insights on more than 20 million websites and services to help publishers demonstrate the unique value of their audiences … Continue reading “Quantcast Secures $7,999,999 Series C Funding Round”
Allozyne Receives New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da419c99-6e8d-4779-95c1-f47d48cf6fb9&Preview=1 Date 12/23/2011 Company Name Allozyne Mailing Address 1600 Fairview Ave E Seattle, WA 98102 Company Description Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics. Website http://www.allozyne.com Transaction Type Venture … Continue reading “Allozyne Receives New Round”
Google’s New Seattle Director: Cloud Expert Doug Orr
Google’s new site director in Seattle is Doug Orr, a senior engineer at the tech giant who was working most recently on cloud computing projects, two sources tell Xconomy. Orr takes over for Brian Bershad, a former University of Washington professor who is now working for Google in Russia, one of our sources confirms. Word of Bershad’s … Continue reading “Google’s New Seattle Director: Cloud Expert Doug Orr”
Potential Treatment for Degenerative Eye Diseases Developed at Wayne State
Former Wayne State University opthalmology researchers Raymond Iezzi and Rangaramanujam Kannan have developed a new way to treat age-related macular degeneration and retinitis pigmentosa using injections of nanoparticles, the university announced earlier this month. Iezzi, who has since gone on to the Mayo Clinic, and Kannan, who is now with Johns Hopkins, are currently in … Continue reading “Potential Treatment for Degenerative Eye Diseases Developed at Wayne State”
San Diego Life Sciences Roundup: Intellikine, Somaxon, and More
—Merry Christmas, Troy Wilson! Japan’s Takeda Pharmaceutical agreed to pay $190 million upfront, plus another $120 million in future milestone payments, to acquire Intellikine, the San Diego biotech that CEO Wilson co-founded in 2007. Takeda wants to combine Intellikine’s portfolio of small molecule drugs in the PI3 kinase pathway, a hot target in cancer biology, … Continue reading “San Diego Life Sciences Roundup: Intellikine, Somaxon, and More”
Social Media Week
This week-long conference will explore the role of social media in industries ranging from education to healthcare. Speakers include Gabe Zichermann, CEO of Gamification, Jay Walker, chairman and curator of TEDMED, and David Eastman, CEO of JWT North America. For more information, click here.
Jawbone, Stion, Houzz: Bay Area BizTech by the Numbers
Time for our data-driven roundup of the latest deals news from around the San Francisco Bay Area. $17 to $18 billion—The approximate amount Yahoo could raise by selling off its stakes in China’s Alibaba and Yahoo Japan, according to reports today from Fortune and Dow Jones VentureWire. Yahoo’s board is reportedly considering the transactions this … Continue reading “Jawbone, Stion, Houzz: Bay Area BizTech by the Numbers”
PatientKeeper Inks $6M, Promotes Hazard to Chairman
Waltham, MA-based health IT company PatientKeeper announced today that it has added $6 million in growth financing, from Flybridge Capital Partners, New Enterprise Associates and Whitney & Company. The company, which makes software for improving patient care and physician workflow, said the new money will go to product development and the expansion of its professional … Continue reading “PatientKeeper Inks $6M, Promotes Hazard to Chairman”
Report: Amazon Opening Boston-Area Office
I guess Werner Vogels changed his mind. Amazon.com’s chief technology officer told me a couple years ago that his company had no intention of opening a Boston office. MIT engineers, he said, had no problem moving out west to Seattle to join the e-retail technology giant. I thought that was kind of strange, but Amazon … Continue reading “Report: Amazon Opening Boston-Area Office”
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy
Seattle-based Allozyne spent the last six months trying to go public by merging into the shell of what used to be an active, publicly traded biotech company. But in the end, the deal fell apart. Allozyne and San Francisco-based Poniard Pharmaceuticals (NASDAQ: [[ticker:PARD]]) said today in a statement they have “mutually agreed to terminate” the … Continue reading “Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy”
Innovation on Call: Insights from the Stratos Idea Factory
It’s been said plenty of times: If the U.S. wants to get out of this seemingly neverending economic malaise, we’ll have to innovate our way out. It’s a good idea, and a great slogan. But actually making it happen is not so easy. Sean MacLeod, president of Seattle’s Stratos Product Development, sees this kind of … Continue reading “Innovation on Call: Insights from the Stratos Idea Factory”
CrowdOptic Taps Smartphones to Track the Crowd’s Attention
The idea behind CrowdOptic, a service that allows event organizers to figure out what a crowd is looking at by tapping their smartphones, came to CEO and co-founder Jon Fisher last year during a routine meeting. As he sat down to chat with an investor in one of his earlier companies, he caught sight of … Continue reading “CrowdOptic Taps Smartphones to Track the Crowd’s Attention”
Akamai to Buy Cotendo for $268M
Some big acquisition news before the holidays here. Cambridge, MA-based Akamai Technologies (NASDAQ: [[ticker:AKAM]]), the Web delivery and networking giant, said today it is acquiring a competitor, Sunnyvale, CA-based Cotendo, for $268 million in cash. The deal, which has been rumored for the past month, is expected to close in the first half of 2012. … Continue reading “Akamai to Buy Cotendo for $268M”
Early Pharma Partnership Proves Key to Armgo’s Startup Success
On February 1, Armgo Pharma CEO Sapan Shah will join Aisling Capital’s Dennis Purcell on stage at Xconomy’s first big New York conference to tell the inside story of how Aisling turned a Columbia University discovery into a promising biotech company. No doubt much of the discussion will revolve around a French pharmaceutical company called … Continue reading “Early Pharma Partnership Proves Key to Armgo’s Startup Success”
How Not to Name a Startup: The Curse of the Camel Case
What’s in a tech startup name? More specifically, is there a correlation between the type of name a company has and its success? That’s a question every startup founder and investor should be interested in. Because if there is a correlation, then using a name-based strategy for picking winners would be, well, about as good … Continue reading “How Not to Name a Startup: The Curse of the Camel Case”
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups
This was a great year for Seattle biotech if you measure success through sheer number of acquisitions. But if you prefer to measure the health of an innovation community by the number of exciting new startups it hatches, then this was most certainly a down year. That’s the mixed bag of returns that I saw … Continue reading “The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups”
Boston-Power Adds $30M to Bring Venture Funding Pot to $346M
Anyone who says cleantech companies are having a tough time raising money should take a look at Boston-Power. The Westborough, MA-based advanced lithium-ion battery maker is announcing today that it’s taken in $30 million in equity funding, just three months after announcing a massive $125 million Series F funding round. The company has now attracted … Continue reading “Boston-Power Adds $30M to Bring Venture Funding Pot to $346M”
Boston-Power Obtains $30,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c924bc5f-fa0a-404e-960b-042cbef36977&Preview=1 Date 12/22/2011 Company Name Boston-Power Mailing Address 2200 West Park Drive Westborough, MA 01581 Company Description Boston-Power, Inc. is an emerging portable power company answering the call for safer, longer lasting Lithium-ion batteries – today. Website http://www.boston-power.com Transaction Type Venture Equity Transaction Amount $30,000,000 Transaction Round Undisclosed Proceeds Purposes The investment … Continue reading “Boston-Power Obtains $30,000,000 New Financing Round”
Cyber-Ark Software Receives $40,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7108e0a4-4eb9-4abc-9a1f-387c902e1da8&Preview=1 Date 12/22/2011 Company Name Cyber-Ark Software Mailing Address 57 Wells Avenue Newton, MA 02459 Company Description Cyber-Ark Software is a global information security company that specializes in protecting and managing privileged users, applications and sensitive information to improve compliance, productivity and protect organizations against insider threats and advanced external threats. Website … Continue reading “Cyber-Ark Software Receives $40,000,000 New Round”